Bionano Genomics Inc. (BNGO) Operating Margin

Bionano Genomics Inc. (BNGO) - corporate logo

The efficiency of Bionano Genomics, Inc. (BNGO) is based on the cost of genome analysis and the implementation of technologies within laboratories. The ecosystem they are creating identifies hidden DNA defects, becoming a scientific standard. The annual operating margin clearly confirms these processes, where the -97.10 level serves as a critical benchmark. However, fierce market competition and pressure from major players are forcing the company to reduce equipment costs.

BNGO: Bionano Operating Sales Margin 07/04/2022 - 11/20/2026

Bionano Genomics Inc. - analytical breakdowns and key metrics (BNGO)

- price and consensus price forecast:
Initial company analysis:BNGO, Bionano
Brand item of Bionano Genomics

Operating margin measures the share of profit from core business processes before debt service and taxes, reflecting real-time efficiency in cost management. Analyzing the operating margin allows investors to assess the sustainability of the Bionano Genomics, Inc. (BNGO) model, where the high cost of maintaining elite geneticists and cutting-edge laboratories must be balanced by revenue growth from genome mapping systems.

Competing companies

Operating Sales Margin TEM|QGEN - Operating Profitability Margin|Operating Margin IONS|RGEN - Operating Return on Sales|Operating Profitability Avidity RNA|Operating Margin CRISPR Therapeutics Corp CRSP|GeneDx Corp - Operating Margin|Ultragenyx Pharma (RARE) - Operating Sales Margin|beamtx.com (BEAM) - Operating Profitability|SRPT: Operating Profit Ratio|Operating Sales Margin TWST|TXG - Operating Profitability Margin|Operating Margin NTLA|Profitability of Operations Stoke Therapeutics|Operating Profitability BioLife Solutions BLFS|Wave Life Sciences (WVE) - Operating Return on Sales|Maze Therapeutics, Inc. - Operating Margin|Profitability of Operations Sionna Therapeutics, Inc. SION|Prime Medicine Bio (PRME) - Operating Profitability|TSHA: Operating Profit Ratio|Operating Profitability uniQure Pharma|MGTX - Operating Profitability Margin|Operating Margin RGNX|Operating Profitability SLDB (Solid Biosciences)|Ocugen Corp - Operating Sales Margin|PACB: Return on Sales by Operating Profit|benitec.com - Operating Margin|DSGN - Operating Margin|RCKT: Operating Margin|FDMT (4D Molecular Therapeutics Inc) - Operating Profitability|Operating Sales Margin LXEO|Operating Profitability KRRO|Operating Margin EDIT|SLN - Operating Return on Sales|Operating Margin PRQR (ProQR)|CDXS - Operating Sales Margin|Sangamo Therapeutics Inc. - Operating Margin|NAUT - Operating Margin|MGX: Operating Margin|Operating Sales Margin Precision BioSciences, Inc.|GBIO (Generation Bio) - Operating Margin|Boundless Bio Inc. (BOLD) - Profitability of Operations|Operating Sales Margin XCUR (exicuretx.com)|Imunon Inc - Return on Sales by Operating Profit|Operating Margin PHIO (Phio Pharmaceuticals Corp)|Operating Profit Rate MBIO|RNAZ - Operating Profitability|APDN (Applied DNA Sciences Inc) - Return on Sales by Operating Profit|BLUE (Bluebird Bio) - Operating Sales Margin|ImmunoPrecise Antibodies Ltd - Operating Profit Rate|OMGA (Omega Therapeutics Inc) - Operating Margin|Operating Profitability OMIC|Operating Profitability Regulus Therapeutics Inc. (RGLS)|Operating Sales Margin Syros Pharmaceuticals, Inc. SYRS|Telesis Bio - Operating Sales Margin|Operating Profit Rate TCON|UBX - Operating Profitability